BNR
Burning Rock Biotech Ltd
$0.8
Earnings Summary
Revenue | $127.57Mn |
Net Profits | $-174.98Mn |
Net Profit Margins | -137.17% |
Highlights
Burning Rock Biotech Ltd’s revenue fell -17.5% since last year same period to $127.57Mn in the Q3 2023. On a quarterly growth basis, Burning Rock Biotech Ltd has generated -12.79% fall in its revenue since last 3-months.
Burning Rock Biotech Ltd’s net profit jumped 22.68% since last year same period to $-174.98Mn in the Q3 2023. On a quarterly growth basis, Burning Rock Biotech Ltd has generated -33.33% fall in its net profits since last 3-months.
Burning Rock Biotech Ltd’s net profit margin jumped 6.28% since last year same period to -137.17% in the Q3 2023. On a quarterly growth basis, Burning Rock Biotech Ltd has generated -52.87% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Burning Rock Biotech Ltd post its latest quarter earnings
EPS Estimate Current Quarter | -1.1 |
EPS Estimate Current Year | -1.1 |
Highlights
Burning Rock Biotech Ltd’s earning per share (EPS) estimates for the current quarter stand at -1.1 - a 14.73% jump from last quarter’s estimates.
Burning Rock Biotech Ltd’s earning per share (EPS) estimates for the current year stand at -1.1.
Key Ratios
Key ratios of the Burning Rock Biotech Ltd post its Q4 2023 earnings
Earning Per Share (EPS) | -0.22 |
Highlights
Burning Rock Biotech Ltd’s earning per share (EPS) jumped 33.58% since last year same period to -0.22 in the Q4 2023. This indicates that the Burning Rock Biotech Ltd has generated 33.58% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-06-30 | -1.86 | -1.28 | 31.18% |
2023-04-20 | -2.45 | -1.81 | 26.12% |
2024-03-29 | -1.29 | -0.22 | 83.01% |
₹0 US Stocks a/c Opening Fee